Every year, millions of plasma donations are transformed into life-saving treatments for people with rare and chronic diseases—but the process takes 9 to 12 months from donation to delivery.

Inside Chase Feiger's newest Forbes piece, he sits down with Giles Platford, President of the Takeda Plasma-Derived Therapies Business Unit, to discuss the challenges and breakthroughs shaping the future of PDTs.

-The logistical and policy hurdles in ensuring a stable plasma supply

- How Takeda is scaling its operations to improve global access

-The role of AI & automation in streamlining plasma collection and manufacturing

‍

Head over to the full article to read more >>>>

‍

‍

‍